Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism

Fig. 1

Expression of FSHR and HK2 in cancer cell lines. a FSHR and HK2 expression in ovarian cancer A2780, A2780CP and OVCAR8 cells, lung cancer H1299 cells, and liver cancer HepG2 cells were detected by western blotting. b FSHR and HK2 expression in A2780 and A2780CP tumor xenografts of nude mice detected by immunohistochemistry (200X)

Back to article page